Get Real Time Here
| Open40.020 | Close39.950 |
| Vol / Avg.732.927K / 901.497K | Mkt Cap5.277B |
| Day Range39.470 - 41.064 | 52 Wk Range29.850 - 59.390 |
Halozyme Therapeutics Stock (NASDAQ:HALO), Quotes and News Summary
Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.
| Open40.020 | Close39.950 |
| Vol / Avg.732.927K / 901.497K | Mkt Cap5.277B |
| Day Range39.470 - 41.064 | 52 Wk Range29.850 - 59.390 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.730 | 0.750 | 0.0200 | ||||
| REV | 222.630M | 216.033M | -6.597M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-10-20 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 50.00 |
| 2023-10-19 | HC Wainwright & Co. | Mitchell Kapoor | Maintains | BuyBuy | Raises | 60.00 | 61.00 |
| 2023-10-09 | HC Wainwright & Co. | Mitchell Kapoor | Reiterates | BuyBuy | Maintains | - | 60.00 |
| 2023-09-08 | HC Wainwright & Co. | Mitchell Kapoor | Reiterates | BuyBuy | Maintains | - | 60.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HALO | Halozyme Therapeutics | -0.5% | 5.3B |
| IMVT | Immunovant | -2.68% | 5.7B |
| RARE | Ultragenyx Pharmaceutical | -2.32% | 3.3B |
| MLTX | MoonLake | 2.39% | 3.4B |
| KRTX | Karuna Therapeutics | -0.37% | 7.8B |
How do I buy Halozyme Therapeutics (HALO) stock?
You can purchase shares of Halozyme Therapeutics (NASDAQ: HALO) through any online brokerage.
Who are Halozyme Therapeutics's (HALO) competitors?
Other companies in Halozyme Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Karuna Therapeutics (NASDAQ:KRTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the target price for Halozyme Therapeutics (HALO) stock?
The latest price target for Halozyme Therapeutics (NASDAQ: HALO) was reported by Benchmark on Friday, October 20, 2023. The analyst firm set a price target for 50.00 expecting HALO to rise to within 12 months (a possible 25.16% upside). 21 analyst firms have reported ratings in the last year.
Current Stock Price for Halozyme Therapeutics (HALO)?
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $39.95 last updated December 8, 2023 at 9:20 PM UTC.
Does Halozyme Therapeutics (HALO) pay a dividend?
There is no dividend information for Halozyme Therapeutics.
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
Halozyme Therapeutics’s Q4 earnings are confirmed for Tuesday, February 20, 2024.
Is Halozyme Therapeutics (HALO) going to split?
There is no upcoming split for Halozyme Therapeutics.
What sector and industry does Halozyme Therapeutics (HALO) operate in?
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.